Literature DB >> 9423257

Establishing equivalence of two treatments and sample size requirements in matched-pairs design.

J M Nam1.   

Abstract

Statistical methods for testing the null hypothesis of a nonzero difference between two treatments and the sample size determination for matched-pairs studies are investigated. A Wald-type test proposed by Lu and Bean (1995, Statistics in Medicine 14, 1831-1839) is anticonservative, i.e., its false positive error rate is greater than specified. Score method and normal deviate based on a restricted maximum likelihood estimation are presented. These two test statistics are shown to be algebraically equal. Their actual type I error probabilities are satisfactorily close to a nominal level. Numerical examinations demonstrate that the sample size formulas using these alternative methods are reasonable while that by Lu and Bean is not. The efficiency of matching in equivalence studies is positively related to intercorrelation or the kappa coefficient of agreements. We recommend the score or ML methods to establish equivalence of two treatments for individually matched samples.

Entities:  

Mesh:

Year:  1997        PMID: 9423257

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  11 in total

1.  Effectiveness of a quality-improvement program in improving management of primary care practices.

Authors:  Joachim Szecsenyi; Stephen Campbell; Bjoern Broge; Gunter Laux; Sara Willms; Michel Wensing; Katja Goetz
Journal:  CMAJ       Date:  2011-10-31       Impact factor: 8.262

2.  Power and sample size requirements for non-inferiority in studies comparing two matched proportions where the events are correlated.

Authors:  Jun-Mo Nam
Journal:  Comput Stat Data Anal       Date:  2011-10-01       Impact factor: 1.681

3.  A note on monotonicity assumptions for exact unconditional tests in binary matched-pairs designs.

Authors:  Xiaochun Li; Mengling Liu; Judith D Goldberg
Journal:  Biometrics       Date:  2011-04-05       Impact factor: 2.571

4.  Non-inferiority tests for clustered matched-pair data.

Authors:  Jun-Mo Nam; Deukwoo Kwon
Journal:  Stat Med       Date:  2009-05-30       Impact factor: 2.373

5.  A Comparison of Testing Parameters and the Implementation of a Group Sequential Design for Equivalence Studies Using Paired-sample Analysis.

Authors:  Yunda Huang; Steven G Self
Journal:  Stat Biopharm Res       Date:  2012-01-01       Impact factor: 1.452

6.  Small incision lenticule extraction (SMILE) versus laser in-situ keratomileusis (LASIK): study protocol for a randomized, non-inferiority trial.

Authors:  Marcus Ang; Donald Tan; Jodhbir S Mehta
Journal:  Trials       Date:  2012-05-31       Impact factor: 2.279

7.  The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.

Authors:  A W Postema; M J V Scheltema; C K Mannaerts; R J G Van Sloun; T Idzenga; M Mischi; M R E Engelbrecht; J J M C H De la Rosette; H Wijkstra
Journal:  BMC Urol       Date:  2017-04-05       Impact factor: 2.264

8.  Efficient Noninferiority Testing Procedures for Simultaneously Assessing Sensitivity and Specificity of Two Diagnostic Tests.

Authors:  Guogen Shan; Amei Amei; Daniel Young
Journal:  Comput Math Methods Med       Date:  2015-08-20       Impact factor: 2.238

9.  Non-inferiority of retrospective data collection for assessing perioperative morbidity.

Authors:  Amour B U Patel; Anna Reyes; Gareth L Ackland
Journal:  PeerJ       Date:  2015-12-01       Impact factor: 2.984

10.  Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial.

Authors:  Yuko Kanbayashi; Koichi Sakaguchi; Takeshi Ishikawa; Yoshimi Ouchi; Katsuhiko Nakatsukasa; Yusuke Tabuchi; Fuminao Kanehisa; Minako Hiramatsu; Ryo Takagi; Isao Yokota; Norito Katoh; Tetsuya Taguchi
Journal:  Breast       Date:  2019-12-20       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.